Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins:: HIV, SIV, and HCV envelopes and influenza hemagglutinin

被引:375
作者
Zhang, M
Gaschen, B
Blay, W
Foley, B
Haigwood, N
Kuiken, C
Korber, B
机构
[1] Los Alamos Natl Lab, Theoret Biol Grp, Los Alamos, NM 87544 USA
[2] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[3] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[4] Santa Fe Inst, Santa Fe, NM 87501 USA
关键词
immune escape; N-linked glycosylation; neutralization antibody; variability; virus;
D O I
10.1093/glycob/cwh106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human and simian immunodeficiency viruses (HIV and SIV), influenza virus, and hepatitis C virus (HCV) have heavily glycosylated, highly variable surface proteins. Here we explore N-linked glycosylation site (sequon) variation at the population level in these viruses, using a new Web-based program developed to facilitate the sequon tracking and to define patterns (www.hiv.lanl.gov). This tool allowed rapid visualization of the two distinctive patterns of sequon variation found in HIV-1, HIV-2, and SIV CPZ. The first pattern (fixed) describes readily aligned sites that are either simply present or absent. These sites tend to be occupied by high-mannose glycans. The second pattern (shifting) refers to sites embedded in regions of extreme local length variation and is characterized by shifts in terms of the relative position and local density of sequons; these sites tend to be populated by complex carbohydrates. HIV, with its extreme variation in number and precise location of sequons, does not have a net increase in the number of sites over time at the population level. Primate lentiviral lineages have host species-dependent levels of sequon shifting, with HIV-1 in humans the most extreme. HCV E1 and E2 proteins, despite evolving extremely rapidly through point mutation, show limited sequon variation, although two shifting sites were identified. Human influenza A hemagglutinin H3 HA1 is accumulating sequons over time, but this trend is not evident in any other avian or human influenza A serotypes.
引用
收藏
页码:1229 / 1246
页数:18
相关论文
共 97 条
[41]   Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function [J].
Kottilil, S ;
Chun, TW ;
Moir, S ;
Liu, SY ;
McLaughlin, M ;
Hallahan, CW ;
Maldarelli, F ;
Corey, L ;
Fauci, AS .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (07) :1038-1045
[42]  
Kuiken C.L., 1999, MOL EVOLUTION HIV
[43]   Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum [J].
Land, A ;
Braakman, I .
BIOCHIMIE, 2001, 83 (08) :783-790
[44]  
LEONARD CK, 1990, J BIOL CHEM, V265, P10373
[45]   Host-cell-specific glycosylation of HIV-2 envelope glycoprotein [J].
Liedtke, S ;
Geyer, R ;
Geyer, H .
GLYCOCONJUGATE JOURNAL, 1997, 14 (07) :785-793
[46]   Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR [J].
Lin, G ;
Simmons, G ;
Pöhlmann, S ;
Baribaud, F ;
Ni, HP ;
Leslie, GJ ;
Haggarty, B ;
Bates, P ;
Weissman, D ;
Hoxie, JA ;
Doms, RW .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1337-1346
[47]   Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region [J].
Losman, B ;
Bolmstedt, A ;
Schonning, K ;
Björndal, Å ;
Westin, C ;
Fenyö, EM ;
Olofsson, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (11) :1067-1076
[48]   V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCRS receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies [J].
Ly, A ;
Stamatatos, L .
JOURNAL OF VIROLOGY, 2000, 74 (15) :6769-6776
[49]   The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors [J].
Malenbaum, SE ;
Yang, D ;
Cavacini, L ;
Posner, M ;
Robinson, J ;
Cheng-Mayer, C .
JOURNAL OF VIROLOGY, 2000, 74 (23) :11008-11016
[50]  
Marshall R D, 1974, Biochem Soc Symp, P17